| Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732) |
|---|
| 11/10/2009 | US7615137 Process for recovering caprolactam from aqueous caprolactam product using in situ prepared alkali amino caproate |
| 11/05/2009 | US20090274632 Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in composition and use thereof |
| 11/04/2009 | CN101573333A Inhibitors of histone deacetylase |
| 11/03/2009 | US7612103 Such as 14-O-[4-hydroxy-N-valyl-piperidin-3-yl]-sulfanylacetylmutilin |
| 10/29/2009 | US20090270614 Optically active quaternary ammonium salt having axial asymmetry and process for producing alpha-amino acid and derivative thereof with the same |
| 10/29/2009 | US20090270365 such as N-(2,4-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-2-(piperidin-1-ylmethyl)biphenyl-4-carboxamide, having vanilloid receptor 1 antagonistic activity, used as analgesics |
| 10/27/2009 | US7608617 N,N-alkylene-6-(piperidin-1-ylalkoxy)naphthalene-2-carboxamide derivatives, e.g., piperidin-1-yl-[6-(3-piperidin-1-yl-propoxy)-naphthalen-2-yl]-methanone and 3,4-dihydro-1H-isoquinolin-2-yl)-[6-(3-piperidin-1-yl-propoxy)-naphthalen-2-yl]-methanone; especially for treating obesity |
| 10/27/2009 | CA2415966C Tetrahydro-heterocycloazepinyl pyrimidine derivatives |
| 10/22/2009 | US20090264645 Benzoimidazole compounds |
| 10/22/2009 | US20090264419 CYCLIC MALONAMIDES AS INHIBITORS OF Abeta PROTEIN PRODUCTION |
| 10/22/2009 | US20090264414 Amide Derivatives and Pharmaceutical Use Thereof |
| 10/22/2009 | US20090264404 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disorders |
| 10/21/2009 | EP2109604A1 6-oxo-6,7-dihydro-5h-dibenzo[b,d]azepin-7-yl derivatives |
| 10/21/2009 | EP1608374B9 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders |
| 10/20/2009 | US7605288 2,5-(Aminocarbonylalkylene-(3,5-dihydroxy,6-halo-1,2-phenylene)-carbonyloxyalkylene)-)-p-quinone; chimera, mimetics of radicicol and geldanamycin; anticarcinogenic agents; antitumor agents; decreased toxicity; increased solubility and selectivity; enzyme inhibitors |
| 10/15/2009 | WO2009124940A1 Ivabradine hydrobromide |
| 10/15/2009 | US20090259039 Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance |
| 10/15/2009 | US20090258901 Ligands for monoamine receptors and transporters, and methods of use thereof |
| 10/15/2009 | US20090258858 Muscarinic acetylcholine receptor antagonists |
| 10/13/2009 | CA2471666C An improved process for the preparation of oxcarbazepine and related intermediates |
| 10/08/2009 | US20090253904 Process for the Preparation of a Tetrahydro-1H-Azepines |
| 10/08/2009 | US20090253654 Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |
| 10/07/2009 | EP1833798B1 A process for the preparation of (s)-(+)-10,11-dihydro-10-hydroxy-5h-dibenz[b,f]azepine-5-carboxamide |
| 10/07/2009 | EP1633719B1 Substituted spirobenzazepines |
| 10/07/2009 | CN101550085A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 10/06/2009 | US7598237 7-aryl 1,5-dihydro-4,1-benzoxazepin-2(3H)-one derivatives and their use as progesterone receptor modulators |
| 10/01/2009 | US20090247506 Antibacterial agents |
| 09/30/2009 | CN101544605A Ivabradine and method for preparing pharmaceutically acceptable addition salt thereof |
| 09/29/2009 | CA2407173C Process for the preparation of 10-methoxycarbamazepine |
| 09/29/2009 | CA2349330C Nitrogen containing heterobicycles as factor xa inhibitors |
| 09/23/2009 | CN101538242A Synthetic method of Benazepril key intermediate S-amino substance |
| 09/17/2009 | US20090233909 Sulfonamide compounds as cysteine protease inhibitors |
| 09/16/2009 | EP2099743A2 Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof |
| 09/16/2009 | CN101531565A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 09/11/2009 | WO2009111004A1 Processes for the preparation of intermediates related to the 5-ht2c agonist (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine |
| 09/11/2009 | WO2009110468A1 Potassium channel opener |
| 09/10/2009 | US20090227565 Biphenyl Vasopressin Agonists |
| 09/09/2009 | EP2098512A1 Compounds and methods for treating dyslipidemia |
| 09/09/2009 | EP2098508A1 Cyclic derivatives as modulators of chemokine receptor activity |
| 09/09/2009 | EP2097383A2 Process for preparation of ivabradine hydrochloride |
| 09/09/2009 | EP1838677B1 Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride |
| 09/09/2009 | EP1670768B1 Compounds and methods for treating dyslipidemia |
| 09/08/2009 | US7585976 chemical intermediate for Hemiasterlin, first isolated from the sponge Hemiasterella; anticarcinogenic agent for treatment of colon cancer, tumor; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting |
| 09/08/2009 | US7585878 2-[(2,5-dimethylpyrrolidin-1-yl)methyl]-N-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)biphenyl-4-carboxamide; capsaicin receptor VR1 inhibitory activity; inflammatory pain and neurogenic pain, migraine, cluster headache, bladder diseases including overactive bladder |
| 09/08/2009 | US7585855 Bengamides with a substituted caprolactam cycle, method for the preparation thereof, compositions containing them and use thereof |
| 09/03/2009 | WO2009107389A1 Tricyclic compound |
| 09/03/2009 | US20090221614 Selective serine/threonine kinase inhibitors |
| 09/02/2009 | EP2096104A1 Organic diamines as mGluR7 modulators |
| 09/02/2009 | EP1794129A4 Synthesis by chiral diamine-mediated asymmetric alkylation |
| 09/02/2009 | EP1572215B1 Benzo[d]azepine derivatives for the treatment of neurological disorders |
| 09/01/2009 | US7582774 reacting hydroxyamine with succinic anhydride, or succinic acid to produce N-hydroxysuccinimide; using solvent undergoing azeotropy with water while carrying out dewatering; oxidizing agents for use photography developers, reagents for synthetically preparing peptides; intermediates for insecticides |
| 09/01/2009 | US7582654 Antiarrhythmia agents, treating gastrointensinal disorder, gastroesophageal reflux, chronic obstructive pulmonary disease, diabetes;N-cotnaining heterocyclic compound with carbamate or amide groups and indazole ring |
| 08/27/2009 | WO2007003934A3 17beta-hydr0xyster0id dehydrogenase type 3 (17beta-hsd3 ) inhibitors |
| 08/27/2009 | US20090216013 e.g.1,1-Dicyclohexyl-3-[5-(pyridin-2-ylsulfanyl)-thiazol-2-yl]-urea; useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial, in particular, type 2 diabetes |
| 08/27/2009 | US20090215736 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid |
| 08/26/2009 | CN101516867A Aryl sulfonamides with an analgesic action |
| 08/25/2009 | US7579464 Process for preparation of enantiomerically pure compounds |
| 08/25/2009 | CA2430281C Use of weak opioids and mixed opioid agonists/antagonists for treatment of urinary incontinence |
| 08/20/2009 | US20090209520 2 -oxybenzamide derivatives as parp inhibitors |
| 08/20/2009 | US20090209517 Use of 5H-dibenz/b,f/azepine-5-carboxamide derivatives in the treatment of neuropathic pain and neurological disorders |
| 08/20/2009 | US20090209473 Componds and methods for pormoting angiogenesis |
| 08/19/2009 | CN101508674A Benazepine-2-ketone compound containing ethylene imine ring, preparation and application thereof |
| 08/13/2009 | US20090203902 Asymmetric catalytic reduction of oxcarbazepine |
| 08/13/2009 | US20090203675 Sulfonyl Semicarbazides, Semicarbazides and Ureas, Pharmaceutical Compositions Thereof, and Methods for Treating Hemorrhagic Fever Viruses, Including Infections Associated with Arena Viruses |
| 08/13/2009 | US20090203668 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 08/12/2009 | EP1789395B8 Method for chiral inversion of (s)-(+)- and (r)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and optically enriched mixtures thereof |
| 08/12/2009 | EP1077941B1 Compounds with growth hormone releasing properties |
| 08/12/2009 | CN100526307C Metalloproteinase inhibitors |
| 08/11/2009 | US7572817 Carboxypeptidase U inhibitors; thrombosis, atherosclerosis, adhesions, dermal scarring, cancer, fibrotic conditions, inflammatory diseases; e.g. 2-[(6-Aminopyridin-3-yl)methyl]-3-mercapto-5-[3-(pyrrolidin-1-ylcarbonyl)phenyl]pentanoic acid |
| 08/06/2009 | US20090196919 Oxcarbazepine dosage forms |
| 08/05/2009 | EP1924560B1 6-substituted- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 08/05/2009 | EP1765786A4 An improved process for the preparation of oxcarbazepine and related intermediates |
| 08/05/2009 | EP1445253B1 4,4-difluoro-1, 2, 3, 4-tetrahydro-5h-1-benzazepine derivatives or salts thereof |
| 08/04/2009 | US7569562 1-Methyl-1H-imidazole-4-sulfonic acid (4-bromo-benzyl)-(2-oxo-azepan-3-yl)-amide; for treating or preventing cognitive disorders, such as Alzheimer's Disease |
| 07/30/2009 | US20090192141 Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 07/30/2009 | US20090192095 Amino acid and peptide prodrugs of opioid analgesics with reduced gi side-effects |
| 07/29/2009 | EP1926712B1 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 07/29/2009 | CN100519535C Method for racemisation of (S)-(+)- and (R)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz[b,f]azepine-5-carboxamide and optically enriched mixtures thereof |
| 07/28/2009 | US7566779 1,1'-bi-{4,6-bis(trimethylsilyl)naphthyl}}-2,2'-dimethyl]a- mmonium bromide; reaction of the 2,2'-bishalomethyl binaphthyl with ammonia; chiral phase transfer catalyst easily extracted with a perfluorocarbon solvent for recycle; for stereoselective alkylation of a iminoglycine ester with a alkyl halide |
| 07/28/2009 | US7566707 For example, 2-[3-(Tert-butyloxycarbonylamino)-piperidin-1-yl]-3-(2-butyn-1-yl)-5-[(dibenzo[b,f][1,4]-oxazepin-11-yl)methyl]-3,5-dihydro-imidazo[4,5-d]pyridazin-4-one; inhibiting effect on activity of the enzyme dipeptidylpeptidase-IV; use in treatment of diabetes mellitus, arthritis, obesity |
| 07/23/2009 | WO2009092073A2 Amino acid and peptide prodrugs of opioid analgesics with reduced gi side-effects |
| 07/23/2009 | WO2009092071A2 Amino acid and peptide pro-drugs of phenolic analgesics and uses thereof |
| 07/23/2009 | WO2009023664A3 Substituted azepine- and diazepine-sulfonamides useful to inhibit 11beta-hydroxysteroid dehydrogenase type-1 |
| 07/23/2009 | US20090186874 Carboxamide derivative and use thereof |
| 07/23/2009 | US20090186832 Amino acid peptide pro-drugs of phenolic analgesics and uses thereof |
| 07/22/2009 | EP2007731B1 Process for the preparation of caprolactam cgrp antagonist intermediate |
| 07/22/2009 | CN101490009A Synthesis of acylaminoalkenylene amides useful as substance P antagonists. |
| 07/22/2009 | CN101486679A 5HT2c receptor modulators |
| 07/22/2009 | CN101486678A 5HT2C receptor modulators |
| 07/22/2009 | CN101486677A 5HT2c receptor modulators |
| 07/22/2009 | CN101485664A 5HT2c receptor modulators |
| 07/22/2009 | CN100516047C Lactam compound |
| 07/21/2009 | US7563784 substituted 1,1,4-1l6-trioxo[1,2]thiazepan-4-ylamide-derived protease inhibitors which inhibit the likes of cathepsin K; treating osteoporosis, osteo- and rheumatoid arthritis and periodontal disease; inhibiting excessive cartilage or matrix degradation |
| 07/16/2009 | US20090181951 Parp inhibitors |
| 07/16/2009 | US20090181946 Benzaepinones as Sodium Channel Blockers |
| 07/16/2009 | US20090181940 Imidazopyrazine Tyrosine Kinase Inhibitors |
| 07/15/2009 | EP2006283A9 Process for production of amides or lactams |
| 07/15/2009 | CN101481351A Causticization method for acidamide oil |
| 07/14/2009 | US7560453 Labeling and idagnostic imaging of histamine H3 receptor; therapy for Alzheimer's disease, nervous system disorders, antiepileptic agents, neuropathic pain, Parkinson's disease, multiple sclerosis, strokes, sleep disorders, schizophrenia, attention deficit disorders, drug abruse, antiallergens |
| 07/14/2009 | CA2532818C (thio) carbamoyl-cyclohexane derivatives as d3/d2 receptor antagonists |